News stories about Varian Medical Systems (NYSE:VAR) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Varian Medical Systems earned a daily sentiment score of 0.19 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 45.747888557042 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
These are some of the media stories that may have effected Accern’s scoring:
- Varian Medical Systems (VAR) Releases FY18 Earnings Guidance (americanbankingnews.com)
- Insider Selling: Varian Medical Systems, Inc. (VAR) SVP Sells 7,991 Shares of Stock (americanbankingnews.com)
- Latin America Radiotherapy Market key drivers and challenges 2021 (emailwire.com)
- Varian Medical Systems Inc.: Varian Halcyon Treatment System Receives Taiwan FDA Approval – The Wall Street Transcript (twst.com)
VAR has been the topic of a number of recent analyst reports. Zacks Investment Research lowered Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Citigroup boosted their target price on Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a research report on Monday, October 30th. Evercore ISI initiated coverage on Varian Medical Systems in a research report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 target price on the stock. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, October 29th. Finally, Royal Bank of Canada set a $105.00 target price on Varian Medical Systems and gave the stock a “hold” rating in a research report on Thursday, November 30th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $100.44.
Shares of Varian Medical Systems (NYSE:VAR) traded down $3.04 during mid-day trading on Friday, hitting $108.49. The stock had a trading volume of 1,462,201 shares, compared to its average volume of 634,874. Varian Medical Systems has a twelve month low of $75.54 and a twelve month high of $114.09. The stock has a market capitalization of $9,940.00, a P/E ratio of 39.31, a price-to-earnings-growth ratio of 3.26 and a beta of 0.68.
Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The business had revenue of $739.00 million for the quarter, compared to analysts’ expectations of $741.69 million. During the same quarter in the prior year, the firm posted $1.03 EPS. The business’s quarterly revenue was down 1.1% compared to the same quarter last year. sell-side analysts forecast that Varian Medical Systems will post 4.25 EPS for the current fiscal year.
In other Varian Medical Systems news, insider Dow R. Wilson sold 88,766 shares of the business’s stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $111.00, for a total value of $9,853,026.00. Following the transaction, the insider now owns 155,542 shares in the company, valued at $17,265,162. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Kolleen T. Kennedy sold 931 shares of the business’s stock in a transaction dated Wednesday, October 18th. The shares were sold at an average price of $105.00, for a total value of $97,755.00. Following the completion of the transaction, the executive vice president now owns 27,531 shares in the company, valued at approximately $2,890,755. The disclosure for this sale can be found here. Insiders have sold 111,727 shares of company stock worth $12,392,515 in the last quarter. 0.78% of the stock is currently owned by corporate insiders.
WARNING: This news story was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The original version of this news story can be read at https://ledgergazette.com/2018/01/13/varian-medical-systems-var-receives-daily-news-impact-rating-of-0-19.html.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.